+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

The United Laboratories International Holdings Ltd (3933) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 39 Pages
  • August 2024
  • Region: Global
  • GlobalData
  • ID: 4281930
The United Laboratories International Holdings Ltd (3933) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

The United Laboratories International Holdings Ltd (United Lab) is a pharmaceutical company that manufactures and sells pharmaceutical products. The company offers products through divisions such as preparation products, intermediate products, capsule products, raw material products, and health products. It also provides antibiotics, pharmaceutical raw materials and intermediates, material products and healthcare products. United Laboratories' drug products include amoxicillin capsules, ampicillin capsules, clavulana capsules, levofloxacin hydrochlorid, and cefuroxime axetil tablets, among others. It sells its products through a network of distributors in Europe, North America, East Africa and southeast Asia. United Lab is headquartered in Yuen Long, Hong Kong.

The United Laboratories International Holdings Ltd Key Recent Developments

  • Aug 29, 2023: The United Laboratories International Holdings : Interim Results Announcement For the six months ended 30 June 2023
  • Jun 30, 2023: The United Laboratories International Holdings : Appointment of Independent Non-executive Director and Change in the Composition of Board Committees
  • Mar 31, 2023: United Laboratories International Holdings Announces Resignation of Independent Non-executive Director
  • Mar 21, 2023: The United Laboratories International Holdings Announces 2022 Annual Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • The United Laboratories International Holdings Ltd - Key Facts
  • The United Laboratories International Holdings Ltd - Key Employees
  • The United Laboratories International Holdings Ltd - Key Employee Biographies
  • The United Laboratories International Holdings Ltd - Major Products and Services
  • The United Laboratories International Holdings Ltd - History
  • The United Laboratories International Holdings Ltd - Company Statement
  • The United Laboratories International Holdings Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • The United Laboratories International Holdings Ltd - Business Description
  • Business Segment: Bulk Medicine
  • Overview
  • Performance
  • Business Segment: Finished Products
  • Overview
  • Performance
  • Business Segment: Intermediate products
  • Overview
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: India
  • Performance
  • Geographical Segment: Middle East
  • Performance
  • Geographical Segment: Other Asian Regions
  • Performance
  • Geographical Segment: Other Regions
  • Performance
  • Geographical Segment: PRC, Including Hong Kong (Country of Domicile)
  • Performance
  • Geographical Segment: South America
  • Performance
  • R&D Overview
  • The United Laboratories International Holdings Ltd - Corporate Strategy
  • The United Laboratories International Holdings Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • The United Laboratories International Holdings Ltd - Strengths
  • The United Laboratories International Holdings Ltd - Weaknesses
  • The United Laboratories International Holdings Ltd - Opportunities
  • The United Laboratories International Holdings Ltd - Threats
  • The United Laboratories International Holdings Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Recent Developments
  • Aug 29, 2023: The United Laboratories International Holdings : Interim Results Announcement For the six months ended 30 June 2023
  • Jun 30, 2023: The United Laboratories International Holdings : Appointment of Independent Non-executive Director and Change in the Composition of Board Committees
  • Mar 31, 2023: United Laboratories International Holdings Announces Resignation of Independent Non-executive Director
  • Mar 21, 2023: The United Laboratories International Holdings Announces 2022 Annual Results
Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • The United Laboratories International Holdings Ltd, Key Facts
  • The United Laboratories International Holdings Ltd, Key Employees
  • The United Laboratories International Holdings Ltd, Key Employee Biographies
  • The United Laboratories International Holdings Ltd, Major Products and Services
  • The United Laboratories International Holdings Ltd, History
  • The United Laboratories International Holdings Ltd, Subsidiaries
  • The United Laboratories International Holdings Ltd, Key Competitors
  • The United Laboratories International Holdings Ltd, Ratios based on current share price
  • The United Laboratories International Holdings Ltd, Annual Ratios
  • The United Laboratories International Holdings Ltd, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • The United Laboratories International Holdings Ltd, Performance Chart (2019 - 2023)
  • The United Laboratories International Holdings Ltd, Ratio Charts

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Tasly Pharmaceutical Group Co Ltd
  • Sinovac Biotech Ltd
  • Jinyao Pharmaceutical Co Ltd
  • Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
  • AccuBioTech Co Ltd